McKeon Meunier Carlin & Curfman LLC - US Patent Application Attorneys and Agents

Attorney: McKeon Meunier Carlin & Curfman LLC

Number of applications: 44
Last date: February 24, 2011

Application No.	Application Title	Issue Date
20110045555	ENZYMATIC MODIFICATION OF OIL The disclosed subject matter relates generally to a method for modifying oil, and specifically to a process for increasing the concentration of polyunsaturated fatty acid in an oil composition....	02/24/2011
20110045425	MESO-SCALED COMBUSTION SYSTEM A meso-scaled combustion system. In one aspect, the system has a housing with a housing wall, a top portion defining an exhaust port, and a bottom portion having a bottom surface. A combustion chamber is positioned therein the interior volume of the housing. The combust...	02/24/2011
20110040077	Protein-Responsive Translational Regulatory System Using RNA-Protein Interacting Motif An object of the present invention is to provide a translationally regulatable mRNA which has wider application and can perform specific ON-OFF regulation, an RNA-protein complex specifically bound to the mRNA, and a translational regulatory system. The present inventio...	02/17/2011
20110039916	Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which...	02/17/2011
20110033479	PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES The present invention relates to autoantigens selected from Ezrin, Serpin B5, Peroxiredoxin-2, heat shock protein β1, and/or peptides comprising at least 5 consecutive amino acid residues of one of these autoantigenic proteins having immunological activity, or fragment...	02/10/2011
20110031068	LUBRICATION OF POSITIVE DISPLACEMENT EXPANDERS A method and system for lubricating a positive displacement machine operating as an expander of a compressed gas, comprising introducing into an expansion chamber of the machine a lubricant whose pour point temperature is greater than the operating temperature of the ma...	02/10/2011
20110027600	Fiber Bonding Compositions and Methods of Making and Using Same Fiber bonding compositions are provided comprising a polymer dispersion comprising two or more of a first polymer selected from the group consisting of styrene acrylics and straight acrylics and having a T_gfrom about 35° C. to about 45° C., a second polyme...	02/03/2011
20110020854	Enhancing Endotoxin Detection Provided herein are methods for detecting gram negative bacteria or lipopolysaccharide in a sample. Kits for detecting gram negative bacteria or lipopolysaccharide in a sample are provided....	01/27/2011
20110020288	Reoviruses Having Modified Sequences The invention provides for modified reovirus nucleic acid sequences and modified reovirus polypeptide sequences as well as reoviruses containing such modified nucleic acid or polypeptide sequences. The invention also provides for pharmaceutical compositions that include...	01/27/2011
20110014714	METHOD FOR SELECTIVE LABELING OF PROTEIN PRODUCED BY IN VITRO TRANSLATION BY USING A MARKER FROM TRNA PREPARED BY USING IN VITRO TRANSCRIPTION The present invention relates to a method for the preparation of a labeling material (labeling agent) usable for non-radioactive selective labeling of proteins produced by in vitro translation with fluorophore or biotin; and a method for selective labeling of proteins p...	01/20/2011
20110014471	EASY-TO-SUSPEND HYDROPHOBING AGENTS The invention relates to solids powders comprising particles having an average particle size of 0.1 to 50 μm with predominantly a core-shell structure, wherein the core comprises at least one water-insoluble fatty acid salt and the shell at least one anionic, cationic ...	01/20/2011
20110014155	Reovirus for the Treatment of Cellular Proliferative Disorders Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but ar...	01/20/2011
20110009441	IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS The present invention relates to novel compounds, in particular novel imidazo[1,2-a]piridine derivatives according to Formula (I). The compounds according to the invention are positive allosteric modulators of metabotropic receptors-sub-type 2 (‘mGluR2’) which are u...	01/13/2011
20110008324	Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof An antibody of the invention interacts with human DR5 to produce agonistic or antagonistic effects downstream of the receptor including inhibition of cell proliferation and apoptosis. Nucleic acid sequences and amino acid sequences of anti-DR5 antibodies have been eluci...	01/13/2011
20110004951	METHODS AND COMPOSITIONS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV-1 SUBUNIT-SPECIFIC REVERSE TRANSCRIPTASE This invention relates to methods and compositions for identifying compounds that inhibit HIV-1 subunit-specific reverse transcriptase....	01/06/2011
20110003925	HYDROPHOBIC BINDER MIXTURE, AND CONSTRUCTION MATERIALS MADE THEREFROM The invention relates to a mixture of a calcium sulfate-based mineral binder and at least one additive that imparts hydrophobic properties to the calcium sulfate-based mineral binder. Said additive is a salt, a hydrophilic fatty acid, or a binder mixture containing fatt...	01/06/2011
20110002887	COMBINATIONS OF ANTIBODIES SELECTIVE FOR DR5 AND OTHER THERAPEUTIC AGENTS An antibody of the invention interacts with human DR5 or with human DR4 to produce agonistic or antagonistic effects downstream of the receptor including inhibition of cell proliferation and apoptosis. Methods and uses for the antibodies, optionally in combination with ...	01/06/2011
20110002190	Fiber Feed System For Extruder For Use In Filled Polymeric Products Methods for forming composite materials containing fiber in an extruder are described. A first method includes introducing a polymeric material, an inorganic filler, and a fiber to an extruder. A fiber metering device is used to control the rate the fiber is introduced ...	01/06/2011
20110001255	Vacuum Removal of Entrained Gasses In Extruded, Foamed Polyurethane Methods for forming foamed polyurethane composite materials in an extruder including a vacuum section are described. One method includes introducing a polyol, a di- or poly-isocyanate, and an inorganic filler to a first section of an extruder and mixing the components. ...	01/06/2011
20110000782	ALUMINUM RECOVERY PROCESS Disclosed are processes and electrolytic cells that can be used to extract and thereby recover aluminum from aluminum-containing waste, including an aluminum dross that is suitable for disposal in a land-fill. The disclosed processes and cells use ionic liquids as an el...	01/06/2011
20110000399	FATTY ACID SALT MIXTURE AS A HYDROPHOBING AGENT FOR CONSTRUCTION MATERIALS The invention relates to hydrophobing agents for mineral construction materials, the use thereof, methods for the production thereof, mineral construction materials, and constructional parts. The hydrophobing agents according to the invention contain fatty acid salts th...	01/06/2011
20100331268	Nitrated Lipids and Methods of Making and Using Thereof Described herein are nitrated lipids and methods of making and using the nitrated lipids....	12/30/2010
20100330715	Uniform Transfer of Luminescent Quantum Dots onto a Substrate A method of uniformly transferring luminescent quantum dots onto a substrate, comprising: a) preparing a colloidal suspension of luminescent quantum dots in a hydrophobic solvent, wherein the density of the hydrophobic solvent is from 0.67 g/cm³to 0.96 g/cm<...	12/30/2010
20100330602	Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment The present invention provides a method for preventing or treating cancer or tumorgenesis disorder comprising administering a prevention or treatment effective amount of a p53 mediated secretome component, such as Gal-3, to a patient in need thereof, thereby preventing ...	12/30/2010
20100323356	SMALL RNA-DEPENDENT TRANSLATIONAL REGULATORY SYSTEM IN CELL OR ARTIFICIAL CELL MODEL An object of the present invention is to construct an mRNA which specifically responds to a short RNA sequence and can activate, repress, and regulate the translation of the desired gene, and to construct an artificial cell model system using a liposome comprising the m...	12/23/2010
20100322907	Expansion of Hematopoietic Stem Cells Described herein are methods, compositions and kits related to manipulating hematopoietic stem cells and more particularly to methods, compositions and kits related to increasing the number of hematopoietic stem cells in vitro and in vivo. Also described are methods, co...	12/23/2010
20100319862	IONIC LIQUID SYSTEMS FOR THE PROCESSING OF BIOMASS, THEIR COMPONENTS AND/OR DERIVATIVES, AND MIXTURES THEREOF Disclosed herein are compositions and methods that involve ionic liquids and biomass. Multiphasic compositions involving ionic liquids and a polymer and uses of such compositions for fractioning various components of biomass are disclosed. Methods of making and using co...	12/23/2010
20100317739	HISTONE DEACETYLASE INHIBITORS Novel histone deacetylase inhibitors, including novel fluorescent histone deacetylase inhibitors, are described. Methods for making and using the same, e.g., to treat cancer, are provided....	12/16/2010
20100316609	Conditionally Replicating Viruses for Cancer Therapy Described herein are viral vectors comprising a nucleic acid encoding a viral DNA polymerase wherein the encoded viral DNA polymerase comprises at least one amino acid modification. Also provided are methods of making and using the viral vectors....	12/16/2010
20100311831	Reduction of Sterols and Other Compounds from Oils A process for the removal of sterols, specifically cholesterol, from a triglyceride oil, preferably a marine triglyceride oil, said process comprising contacting an oil with an absorbent, specifically TRIS YL™, clay or a mixture thereof, heating the mixture to 100° C...	12/09/2010
20100300032	PLATE PRODUCT USING NATURAL STONE FOR FLOOR AND WALL FINISHING A plate product for finishing a floor or wall is disclosed. The plate product includes a natural-stone surface plate which has a predetermined thickness and is cut to have a predetermined length and width. A reinforcing plate is cut to have a length and width correspond...	12/02/2010
20100286705	VASCULAR ACCESS TO EXTRA-VASCULAR SPACE Provided are methods for accessing tissue in the vicinity of a blood vessel. Also provided are devices for use in a lumen of a patient's organ and methods for shunting interior volumes of organs....	11/11/2010
20100286674	SYSTEMS, DEVICES AND METHODS FOR IMAGING AND SURGERY Provided herein are devices, systems and methods for imaging of biological tissue. Also provided are devices, systems and methods for surgical manipulation of biological tissue. Further provided are devices, systems and methods for combined imaging and surgical manipula...	11/11/2010
20100286312	Amine Sacrificial Agents and Methods and Products Using Same A method of producing cementitious mixtures containing fly ash as one of the cementitious components, under air entrainment conditions is described. The method involves forming a mixture comprising water, cement, fly ash, optionally other cementitious materials, aggrega...	11/11/2010
20100286212	Treating and Preventing Viral Infections Compounds that are useful in treating or preventing viral infections, such as influenza, are described herein. Further described are compositions made from these compounds and methods for using the compounds and their compositions in treating or preventing viral infecti...	11/11/2010
20100286030	NOVEL BACTERIOCIN FROM A NEW STREPTOMYCES SPECIES Provided is an isolated novel Gram-positive non-motile, non-spore-forming, aerobic bacterium designated Streptomyces scopuloiridis, wherein the bacterium produces a bacteriocin that kills or inhibits the growth of Gram-positive or Gram-negative target bacteria. A...	11/11/2010
20100284967	MODIFIED PHAGE FOR DISPLAYING POST-TRANSLATIONALLY MODIFIED PROTEINS AND USES THEREOF Disclosed herein are modified phage comprising a fusion protein located on the surface of the phage wherein the fusion protein comprises a surface protein and a post-translationally modified protein. Also disclosed are methods of making and using modified phage comprisi...	11/11/2010
20100274215	FLUSHING SOLUTION A flushing solution is described which is suitable for use in surgical, in particular ophthalmological, operations and which contains a non-Newtonian fluid. The use of such a flushing solution is also described....	10/28/2010
20100272929	LABELS An inherently ink printable multi-layer label stock film having a substrate core layer comprising a polymeric material and at least one skin layer which is ink printable, the ink printable skin layer comprising a copolymer of styrene and butadiene and polystyrene in an ...	10/28/2010
20100247622	TREATMENT REGIME FOR PROLIFERATIVE DISORDERS Provided herein are methods for treating or ameliorating a proliferative disorder in a subject. The method contains the steps of administering to the subject one dose of an immunosuppressive agent followed by administering to the subject one to five doses of a reovirus....	09/30/2010

«First «Previous1 2 Next»Last»

PatentStorm

Quotables

PatentStorm News

Attorney: McKeon Meunier Carlin & Curfman LLC